-
Symbol
-
SABS on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
25.9M shares
-
Security Ownership
-
9.99%
Vivo Opportunity Fund Holdings, L.P. ownership in SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS)
2025-10-03 - Vivo Opportunity Fund Holdings, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 25.9M shares of SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS).
This represents 9.99% percent ownership of the company.